Rethinking pediatric clinical trials: guidelines from pediatric experts
In this last episode on pediatric clinical trial challenges, Begoña Nafria, pediatrician and patient engagement
Decentralized Clinical Trials
Essential tips to avoid common pitfalls
Despite the numerous advantages of Decentralized Clinical Trials, reducing on-site visit means that data endpoints need to be captured via other means.
Data must not be lost when patients do not come to site for several weeks, data quality must be guaranteed throughout the project, and data must be protected even when patients use their own mobile.
How can the common pitfalls that come with DCTs be avoided?
#1 Avoiding data loss when patients visit frequency is reduced
#2 Tackling technology adoption risks
#3 Securing data quality when collecting data from multiple sources
#4 Ensuring data protection
READ THE FULL WHITE PAPER:
Learn more:
In this last episode on pediatric clinical trial challenges, Begoña Nafria, pediatrician and patient engagement
In this third episode on pediatric clinical trial challenges, Begoña Nafria, pediatrician and patient engagement
Integrating PROs into studies on MASH, also known as NASH, is crucial. MASH is a debilitating
Asthma clinical trials present several specificities, such as the use of disease-specific health-related quality of
NonAlcoholic SteatoHepatitis (NASH), now called Metabolic Dysfunction-Associated SteatoHepatitis (MASH), affects almost 115 million adults globally
In this second episode on pediatric clinical trial challenges, Begoña Nafria, pediatrician and patient engagement
Last update : 18 October 2022